Fig. 2: Comparison of recurrence-free survival in a subgroup with lymph node metastasis (n = 369).
From: Prognostic difference between early breast cancer patients with HER2 low and HER2 zero status
Red line: patients with HER2-low expression, blue line: patients with HER2-zero expression.
